Jump directly to main navigation Jump directly to content

Institute of Molecular Pathogenesis (IMP)

National Reference Laboratory for Paratuberculosis

Paratuberculosis, also called „Johne´s disease“, is a chronic inflammatory intestinal disease of domestic and wild ruminants and camelids caused by Mycobacterium avium subsp. paratuberculosis (Map). 

After a latency period of several years, clinical symptoms (diarrhea, weight loss and fatigue) are only visible in the final stage of the disease. Chronic diarrhea is observed in cattle and less frequently in goats and camelids, while sheep are mainly characterized by weight loss and fatigue. However, Map is shed in high amounts via faeces also before clinical symptoms occur. Young animals are most susceptible for infection. Paratuberculosis is spread via trade with clinically healthy, latently infected animals. 

The disease, which is reportable in Germany, has been reported from all regions of the country. Up to now it was detected in cattle, sheep, goats, red deer, roe deer, alpacas, different zoo animals and in a donkey. It causes considerable direct and indirect economic losses which are most severe in dairy herds (reduced milk yield, diminished slaughter value because of weight loss, increased susceptibility to other diseases, direct animal losses). 

The zoonotic potential of the disease is controversial. There is still no scientifically proven evidence of a causal link between Crohn's disease, a chronic inflammatory bowel disease of humans, and paratuberculosis. 

Diagnostics of paratuberculosis is based on the detection of the causative agent in faeces and tissues (jejunum, ileum, ileocaecal valve, gut-associated lymph nodes) or on detection of antibodies in blood serum or milk. Detection of the causative agent is done by bacterioscopy (staining of acid-fast bacilli) or by bacteriological culture followed by identification of genome fragments of Map by PCR. Target regions for PCR can be IS900, f57 and others (Möbius et al., Vet. Microbiol. 126: 324-333, 2008.). Meanwhile, molecular detection of genome fragments of MAP in faecal and tissue samples using quantitative real-time PCR is an established diagnostic method. Different real-time PCR-systems for the direct detection of MAP genome fragments in DNA preparations from different specimen have been approved in Germany.

Furthermore, different ELISA assays for the detection of antibodies against Map in serum and milk samples of cattle and in serum of small ruminants are licensed in Germany.

Because of the chronic course of the disease detection of infected animals is delayed for a long time. Especially in young animals (cattle up to at least 2 years of age) a negative test result does not exclude infection. Even in older animals repeated testing is necessary to increase the detection rate. Prevalence estimation is difficult with the established diagnostic methods.

Cultural and/or molecular biological examination of environmental faecal samples or boot swabs proved a cost-efficient approach for the detection of the paratuberculosis herd status even in low prevalence herds. Antibody detection in serum or milk samples of individual animals is also useful for the classification of the infection status of the herd. Antibody detection in pooled milk samples or bulk milk samples allows the identification of herds with high numbers of MAP shedders.

  • Reduction of paratuberculosis incidence in dairy goats by vaccination (ParaVac). EAFRD, European Innovation Partnership for Agriculture, 2020-2023.
  • Volatile organic compounds (VOC) of causative agent and host as biomarker for bacterial infections. (DFG, 2015-2018, Collaboration with WG Pathology and Pathophysiology of the IMP)
  • Volatile organic compounds (VOC) of causative agent and host as biomarker for bacterial infections. (DFG, 2012-2015, Collaboration with WG Pathology and Pathophysiology of the IMP)
  • Identification of host-derived biomarkers of latent infections with Mycobacterium avium ssp. paratuberculosis (MAP). (Part of the EMIDA-ERA-Net consortium „Mycobactdiagnosis“, 2012-2015)
  • Differentiation of Mycobacterium avium subsp. paratuberculosis isolates – Relation between genotype and phenotype. (Partner VI: BMBF-Consortium „ZooMAP“, 2010-2013)
  • Development of improved test systems for the diagnosis, development and testing of vaccines for paratuberculosis. (FLI, Animal Health Insurance (AHI) of Baden-Wuerttemberg, AHI of Hesse, AHI of Mecklenburg-West Pomerania, AHI of Lower Saxony, AHI of Rheinland-Palatine, Thuringian AHI, 2009-2012)
  • Veterinary Network of Laboratories Researching into Improved Diagnosis and Epidemiology of Mycobacterial Diseases. (Co-ordination Action SSPE-CT-2004-501903, VENoMYC, EU, 2004-2010)
  • Differentiation of Mycobacterium avium subsp. paratuberculosis isolates of different origin with a standardized typing protocol. (Partner VI: BMBF Consortium „ZooMAP“, 2007-2010)
  • Evaluation of the efficiency of vaccination for controlling paratuberculosis in cattle. (FLI, 2007-2009).
  • Cultural isolation of Map and other mycobacteria from faeces and tissue
  • Cultural examination of mycobactin-dependence of Map
  • Direct detection of Map in faeces, tissue and environmental samples using real-time PCR
  • Molecular typing of Map (and MAC) using PCR, MIRU-VNTR analysis, MLSSR analysis and a SNP based assay
  • Detection of antibodies against Map in serum and milk using ELISA
  • Consultant for federal and state authorities regarding diagnosis and control of paratuberculosis
  • Clarification of ambiguous test results
  • Molecular typing of Mycobacterium avium subsp. paratuberculosis isolates
  • Supply of reference material for the regional laboratories of the federal states in Germany
  • Experimental evaluation of diagnostic kits for licensing
  • Organization of national proficiency tests
  • Reportable animal disease act
  • Recommendations of hygiene requirements for ruminant husbandry. III. Hygienic measures for particular diseases, 1. Measures for the protection against paratuberculosis in bovine holdings (Banz AT 01.08.2014 B1)
  • Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on animal diseases and amending and repealing certain acts in the area of animal health ("Animal Health Law") (AHL)
  • Commission Implementing Regulation (EU) 2018/1882 of 3 December 2018 on the application of certain disease prevention and control provisions to categories of listed diseases and on the establishment of a list of species and groups of species presenting a significant risk for the spread of those listed diseases
  • Commission Delegated Regulation (EU) 2020/689 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council with regard to rules on surveillance, eradication programmes and disease-free status for certain listed and emerging diseases (DelVO 689/2020)
  • Commission Delegated Regulation (EU) 2018/1629 of 25 July 2018 amending the list of diseases set out in Annex II to Regulation (EU) 2016/429 of the European Parliament and of the Council on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’)